In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Innovation: The Voyage Begins — From Chinese Stents to the Eastern Power in Global Cardiovascular Innovation”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-moderated by Prof. Qixia Jiang, Shanghai General Hospital. Quest for Truth is honored to welcome the distinguished interview guest: Dr. Fernando Alfonso, Hospital Universitario de la Princesa.
In this segment, the discussion moves from isolated innovation to systemic capability. Prof. Gang Wu asks Dr. Fernando Alfonso what makes a sustainable cardiovascular innovation ecosystem, especially in Europe, where clinicians, engineers, researchers, and industry have long worked together in interventional innovation. The conversation also explores what lessons from Europe may help China build a stronger and more collaborative innovation system.
Dr. Fernando Alfonso emphasizes the importance of bridging the gap between basic research and clinical research. He argues that clinicians who see real patients every day should be encouraged to participate in research and understand basic science, because collaboration across basic, translational, and clinical research is becoming increasingly important. He also highlights international collaboration as a key pathway for conducting major trials and answering important clinical questions that can ultimately benefit patients.
When asked what truly drives innovation forward, Dr. Alfonso explains that research begins with necessity. Every failed procedure, complication, or disease recurrence can become a reason for clinicians to seek better solutions. He adds that real innovation requires both expertise and financial support: industry has an important role in funding drug and device research, while scientific societies should also support important “orphan” studies that address gaps in knowledge not driven by commercial interests but essential for patient care.